Avian Chlamydiosis (Psittacosis): Diagnosis and Treatment in Psittacine Birds

PublishedAugust 28, 2026Reading time10 minExoticRx Editorial

Editorially reviewed against published veterinary references. Awaiting credentialed clinical reviewer — our editorial process.

Avian chlamydiosis, caused by the obligate intracellular bacterium Chlamydia psittaci, sits in an unusual clinical category: it is simultaneously a common differential for the sick psittacine, a frequent cause of frustratingly nonspecific presentations, and a reportable zoonosis with genuine human morbidity. The disease it produces in people — psittacosis, or "parrot fever" — ranges from an influenza-like illness to severe atypical pneumonia and, rarely, fatal systemic disease. That dual footprint means the clinician's obligation extends beyond the patient on the table to the household, the practice team, and, in most jurisdictions, a public-health authority. Any psittacine presenting with respiratory signs, biliverdinuria, hepatomegaly, or a "sick bird" picture of unclear origin should have chlamydiosis on the differential list from the outset — and the workup should be conducted with zoonotic precautions in place before the diagnosis is confirmed.

For the psittacine formulary and source-cited dose data referenced throughout this article, see the African grey parrot species page.

Zoonotic significance and why it drives the workup

C. psittaci is transmissible to humans, most often through inhalation of aerosolised respiratory secretions or dried faecal dust from infected birds. Human psittacosis classically presents with fever, headache, myalgia, and a nonproductive cough, and can progress to atypical pneumonia; hepatitis, endocarditis, and encephalitis are described. Immunocompromised individuals, pregnant patients, and the elderly are at elevated risk. Because a shedding bird may appear clinically normal, the human case is sometimes recognised before the avian one.

This shapes practice on two fronts. First, personal protective equipment: suspected cases should be handled with gloves, eye protection, and an N95 (or higher) respirator, ideally in a well-ventilated or negative-pressure area, with wet-cleaning rather than dry-sweeping of enclosures to avoid aerosolising infectious dust. Necropsy of a suspected case warrants particular caution. Second, client counselling: owners must be told, in plain terms, that the infection is transmissible to people, that anyone in the household with a compatible febrile respiratory illness should see their physician and disclose the bird exposure, and that basic hygiene — hand-washing, avoiding face-to-beak contact, cleaning cages wet — reduces risk.

In most jurisdictions avian chlamydiosis is a reportable disease in birds, humans, or both. Know your local requirement before you need it; reporting is covered in more detail below.

Pathogen biology

C. psittaci is a Gram-negative obligate intracellular organism with a biphasic developmental cycle. The infectious, environmentally stable elementary body attaches to and enters the host cell, then differentiates into the metabolically active reticulate body, which replicates within a cytoplasmic inclusion before reorganising back into elementary bodies that are released to infect new cells. This intracellular niche is the reason therapy relies on drugs that penetrate cells well — tetracyclines above all — and why treatment courses are measured in weeks rather than days.

The organism is shed in faeces, respiratory and ocular secretions, and crop secretions. Shedding is frequently intermittent and is amplified by stress — shipping, crowding, breeding, concurrent disease — which is precisely why an apparently healthy carrier can seed an outbreak in an aviary or pet shop and why a single negative test does not clear a bird. Elementary bodies can remain infectious in dried organic material for extended periods, so environmental persistence is a real contributor to transmission.

Clinical signs

The hallmark of avian chlamydiosis is that its signs are nonspecific and variable, ranging from peracute death to inapparent carriage. Reported findings include:

• Lethargy, fluffed posture, anorexia, and weight loss
• Conjunctivitis and periocular swelling; serous to mucopurulent ocular and nasal discharge
• Sinusitis and upper-respiratory signs; dyspnoea and tail-bob in lower-respiratory involvement
• Lime-green to yellow-green urates and biliverdinuria, reflecting hepatic involvement — a classic but not pathognomonic clue
• Hepatomegaly and splenomegaly (often evident on radiographs or at coelioscopy)
• Diarrhoea, sometimes with green mucoid droppings
• Nonspecific neurologic signs in severe systemic disease
• Sudden death with minimal premonitory signs, particularly in young or stressed birds
• Subclinical carriage — the epidemiologically important form, in which the bird appears healthy while intermittently shedding

Signs vary by species and virulence. Some psittacines, notably budgerigars and cockatiels, may harbour infection with little overt illness, whereas heavily stressed or co-infected birds can decompensate rapidly. No single sign confirms the diagnosis; the picture is built from history, signalment, examination, and — critically — laboratory testing conducted under zoonotic precautions.

Diagnostic workup

No single test is perfect, and the intermittency of shedding is the recurring pitfall. Build the diagnosis from complementary methods.

PCR — the test of choice

PCR detection of C. psittaci DNA on a combined choanal and cloacal swab is the current test of choice for antemortem diagnosis, offering high sensitivity and specificity relative to older methods. Because shedding is intermittent, a single negative PCR does not exclude infection in a suspect bird; serial sampling over several days improves detection, and pooled or repeat testing is prudent in a flock investigation. Sample handling matters — follow the reference laboratory's swab and transport-medium instructions, as PCR performance depends on it.

Serology and its limitations

Antibody testing (elementary-body agglutination, immunofluorescence, or complement fixation) detects exposure rather than active shedding. Its limitations are important: antibodies may be absent in early or peracute infection, may persist after clearance, and a single titre cannot distinguish current infection from past exposure. Serology is most informative as paired samples showing a rising titre, or interpreted alongside antigen or PCR results.

Combined antigen plus antibody testing

Because organism-detection and antibody methods fail in different circumstances, combining an antigen/PCR assay with serology improves diagnostic confidence — a strategy explicitly favoured for a pathogen whose shedding is intermittent and whose antibody kinetics are slow. A positive on either arm, in a bird with compatible signs, supports treatment.

Supporting diagnostics

• Haematology and biochemistry: leukocytosis (often marked), with monocytosis and/or heterophilia; anaemia in chronic cases; elevated AST and bile acids reflecting hepatic involvement.
• Imaging: hepatomegaly and splenomegaly on radiographs support the diagnosis.
• Cytology and histopathology: intracytoplasmic inclusions may be seen; at necropsy, fibrinous serositis (airsacculitis, pericarditis, perihepatitis) with hepato- and splenomegaly is characteristic, and post-mortem PCR or immunohistochemistry confirms.

Treatment

The therapeutic principle is straightforward: an intracellular organism requiring a cell-penetrating antimicrobial delivered for a prolonged, uninterrupted course. Doxycycline is the mainstay, and the canonical teaching is a 45-day course to address the intracellular niche and reduce the likelihood of residual carriage. Shorter courses risk incomplete clearance and relapse.

Doxycycline — route and formulation

Doxycycline dosing is route-, formulation-, and species-dependent, and this is where clinicians most often go wrong by transplanting a single number across contexts. Canonical published guidance:

• Oral doxycycline, given once daily for a 45-day course, dosed by species and preparation (Carpenter's Exotic Animal Formulary; Hawkins et al.) — see the Doxycycline drug page and calculator for the exact per-species figure. Smaller psittacines such as cockatiels and budgerigars are frequently dosed toward the higher end of the published range.
• Long-acting injectable doxycycline (e.g. the Vibravenös preparation), given IM at approximately weekly intervals across the treatment course (Carpenter's Exotic Animal Formulary); confirm the exact figure on the Doxycycline drug page. The injectable route improves compliance and is useful in flocks or intractable patients but can cause injection-site reactions, so rotate sites.

Because the correct value is species- and formulation-specific, confirm the exact per-species figure on the Doxycycline drug page and run the weight-based math in the calculator rather than relying on a remembered number. Medicated feed and water protocols exist but give less reliable individual dosing than direct oral or injectable administration.

The calcium interaction and compounding

Oral doxycycline chelates divalent cations — calcium in particular — which impairs absorption. Counsel owners to avoid concurrent calcium-rich foods, cuttlebone, mineral blocks, and calcium/mineral supplements around dosing, and be alert to this interaction when a bird fails to respond. Because commercial formulations are rarely sized for small psittacines, compounding is usually required to achieve accurate, palatable dosing; use a reputable compounding pharmacy and be aware that compounded stability and palatability vary.

Provide supportive care in parallel — warmth, fluids, and assisted nutrition for the debilitated patient — and monitor hepatic and renal parameters over the prolonged course.

Monitoring and prognosis

Assess clinical response — appetite, weight, dropping colour, resolution of ocular and respiratory signs — throughout treatment, and monitor liver enzymes and body weight given the length of therapy. Because shedding is intermittent, post-treatment PCR testing is used to support clearance, ideally with serial rather than single samples. Prognosis is generally good for birds treated early with a complete course; it worsens with peracute presentations, severe hepatic compromise, delayed treatment, or interrupted courses that permit relapse and continued shedding.

Public-health reporting and in-contact bird management

Reporting: In most jurisdictions avian chlamydiosis is notifiable. When you diagnose or strongly suspect a case, follow your local statutory reporting obligations to the relevant animal-health and/or public-health authority, and document that you have counselled the client on the zoonotic risk. The NASPHV Compendium of Measures to Control Chlamydia psittaci Infection Among Humans and Pet Birds is the standard reference framework and is periodically updated.

In-contact birds: Treat exposure as a flock problem, not a single-patient one. All birds that shared air space with a confirmed case should be considered exposed, tested, and — depending on setting and risk — treated as a group, since untreated in-contact carriers perpetuate the cycle. New acquisitions should be quarantined and, ideally, tested before entering a collection. Wet-clean and disinfect the environment; C. psittaci is susceptible to many common disinfectants but persists in dried organic debris, so mechanical cleaning precedes disinfection.

Prevention and client education

• Quarantine and test new birds (typically 30–45 days) before introduction to a household or aviary.
• Reduce stress — the trigger for shedding — through appropriate husbandry, stocking density, and biosecurity.
• Wet-clean enclosures and avoid aerosolising dried droppings; maintain good ventilation.
• Counsel owners on the human-health dimension and the importance of completing the full course even after the bird looks well.
• Source birds responsibly, favouring suppliers with sound biosecurity and health screening.

When to refer

Consider referral to a board-certified avian specialist (ABVP-Avian or ECZM-Avian) when the diagnosis is unclear despite combined testing, when a collection or aviary outbreak requires structured flock management, when the patient is critically ill and needs intensive hospitalisation, or when coordination with public-health authorities and human-health providers exceeds what the primary practice can manage. See related conditions for differentials that overlap with the chlamydiosis presentation.

Sources

• Carpenter JW, Harms CA. Carpenter's Exotic Animal Formulary. Current edition. Elsevier — avian antimicrobial and doxycycline entries.
• Hawkins MG, et al. Avian formulary chapters — psittacine doxycycline dosing by route and formulation.
• Speer BL, ed. Current Therapy in Avian Medicine and Surgery. Elsevier — chlamydiosis diagnosis and management.
• Harrison GJ, Lightfoot TL, eds. Clinical Avian Medicine. Spix Publishing — infectious disease chapters.
• National Association of State Public Health Veterinarians (NASPHV). Compendium of Measures to Control Chlamydia psittaci Infection Among Humans (Psittacosis) and Pet Birds (Avian Chlamydiosis). Current edition.
• Plumb DC. Plumb's Veterinary Drug Handbook. Current edition — doxycycline monograph.

For the live, source-cited doses referenced here, open the Doxycycline drug page and the African grey parrot formulary; every entry shows its evidence level and citation.

Disclaimer

This article is an informational reference for licensed veterinary professionals, technicians, and students. It does not constitute veterinary medical advice and is not a substitute for clinical judgement, current peer-reviewed literature, statutory reporting obligations, or the recommendation of an attending clinician. This article defers all specific dosing to the source-cited drug pages and calculator rather than stating doses in-text; always confirm the exact figure against the current edition of Carpenter's Exotic Animal Formulary and the individual patient before administration. See the full dosage disclaimer.